CytoMed Therapeutics GDTC
NASDAQ GDTC
$0.84 +0.00 (+0.49%)
At close: Nov 11, 2026 · 4:00 PM EST

CytoMed Therapeutics (GDTC) Depreciation & Amortization - Total (2022 - 2026)

Updated

CytoMed Therapeutics (GDTC) recorded Depreciation & Amortization - Total of $88,024 in Q2 2026, up 4.2% from $84,490 a year earlier.

Analysis

CytoMed Therapeutics (GDTC) Depreciation & Amortization - Total (2022 - 2026) Analysis & Trends

For FY2025, CytoMed Therapeutics reported Depreciation & Amortization - Total of -$196,896.

  • Across earlier years, Depreciation & Amortization - Total came in at -$109,842 in FY2024, -$101,866 in FY2023, -$109,246 in FY2022 and -$98,721 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Tot) (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 CytoMed Therapeutics 9.94 Mn -2.19 Mn - 68,774.55
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 68,774.55
Jun 30, 2025 64,909.12
Jun 30, 2024 88,990.17
Jun 30, 2023 109,632.79
Jun 30, 2022 93,246.23
API Access

CytoMed Therapeutics Depreciation & Amortization - Total API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-total&ticker=GDTC&period=max&api_key=YOUR_API_KEY